OXIS TO THE NASDAQ!!!!
Post# of 325
Oxis Biotech, Inc. Announces Appointment of James L. Nelson to Board
1 hour 24 minutes ago - DJNF
TAMPA, Fla., Sept. 15, 2015 /PRNewswire/ -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] and [Euronext Paris: OXI.PA], announced today that James L. Nelson has joined its Business Advisory Board. Oxis is in the process of building a world class Advisory Board to assist management in strategy, development and execution. The Business Advisory Board members will become members of the Oxis Board of Directors upon a successful up-listing to the NASDAQ exchange.
James L. Nelson has served as a director and member of the audit committee of Icahn Enterprises L.P. (IEP) and its general partner, Icahn Enterprises G.P., Inc., since June 2001. Since June 2011, Mr. Nelson has served as a director and member of the compensation, governance and strategic alternatives committees of Voltari Corporation and, since January 2012, Chairman of its Board of Directors. Since April 2014, Mr. Nelson has served as a director and member of the audit committee, of Herbalife Ltd. (HLF), a nutrition company.